These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21512899)

  • 1. Alternating treatment with S-1 plus low-dose cisplatin and S-1 alone for advanced gastric cancer.
    Mita K; Ito H; Fukumoto M; Murabayashi R; Koizumi K; Hayashi T; Kikuchi H; Kagaya T
    J Gastrointest Surg; 2011 May; 15(5):791-6. PubMed ID: 21512899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.
    Koizumi W; Narahara H; Hara T; Takagane A; Akiya T; Takagi M; Miyashita K; Nishizaki T; Kobayashi O; Takiyama W; Toh Y; Nagaie T; Takagi S; Yamamura Y; Yanaoka K; Orita H; Takeuchi M
    Lancet Oncol; 2008 Mar; 9(3):215-21. PubMed ID: 18282805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Chemotherapy with S-1 plus Cisplatin for Patients with Stage III Gastric Cancer After Curative Resection.
    Mita K; Ito H; Ota E; Takahashi K; Hashimoto M; Asakawa H; Hayashi T; Fujino K
    Anticancer Res; 2017 Mar; 37(3):1329-1333. PubMed ID: 28314299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer.
    Lee SS; Jeung HC; Chung HC; Noh SH; Hyung WJ; Ahn JY; Rha SY
    Invest New Drugs; 2012 Feb; 30(1):357-63. PubMed ID: 20734110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer.
    Tsujitani S; Fukuda K; Kaibara N
    Gastric Cancer; 2003; 6 Suppl 1():50-7. PubMed ID: 12775021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106).
    Kurimoto K; Ishigure K; Mochizuki Y; Ishiyama A; Matsui T; Ito S; Nakayama H; Tanaka N; Kobayashi D; Sakamoto J; Nakao A; Kodera Y
    Gastric Cancer; 2015 Apr; 18(2):354-9. PubMed ID: 24838732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.
    Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial.
    Lee CK; Jung M; Kim HS; Jung I; Shin DB; Kang SY; Zang DY; Kim KH; Lee MH; Kim BS; Lee KH; Cheong JH; Hyung WJ; Noh SH; Chung HC; Rha SY
    Cancer Res Treat; 2019 Jan; 51(1):1-11. PubMed ID: 29397659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized phase III trial of postoperative adjuvant therapy with S-1 alone versus S-1 plus PSK for stage II/IIIA gastric cancer: Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC).
    Ueda Y; Fujimura T; Kinami S; Hirono Y; Yamaguchi A; Naitoh H; Tani T; Kaji M; Yamagishi H; Miwa K;
    Jpn J Clin Oncol; 2006 Aug; 36(8):519-22. PubMed ID: 16803844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer.
    Takahari D; Hamaguchi T; Yoshimura K; Katai H; Ito S; Fuse N; Konishi M; Yasui H; Terashima M; Goto M; Tanigawa N; Shirao K; Sano T; Sasako M
    Gastric Cancer; 2014 Apr; 17(2):383-6. PubMed ID: 23719867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer.
    Yamaguchi K; Fuse N; Komatsu Y; Fujii H; Hironaka S; Omuro Y; Muro K; Yasui H; Ueda S; Nishina T; Watanabe M; Ohtsu A
    Jpn J Clin Oncol; 2021 May; 51(6):879-885. PubMed ID: 33561262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S-1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancer.
    Shinkai M; Imano M; Chiba Y; Iwama M; Shiraisi O; Yasuda A; Tsubaki M; Nishida S; Kimura Y; Yasuda T
    J Surg Oncol; 2019 Jan; 119(1):56-63. PubMed ID: 30444009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer.
    Kang BW; Kim JG; Chae YS; Lee YJ; Lee SJ; Moon JH; Sohn SK; Jung MK; Jeon SW; Jang YJ; Seo J; Lee YH; Kwon O; Chung HY; Yu W
    Invest New Drugs; 2012 Aug; 30(4):1671-5. PubMed ID: 21845514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-1 and Cisplatin With or Without Nimotuzumab for Patients With Untreated Unresectable or Metastatic Gastric Cancer: A Randomized, Open-Label Phase 2 Trial.
    Du F; Zheng Z; Shi S; Jiang Z; Qu T; Yuan X; Sun Y; Song Y; Yang L; Zhao J; Wang J; Chi Y
    Medicine (Baltimore); 2015 Jun; 94(23):e958. PubMed ID: 26061330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703).
    Kodera Y; Ishiyama A; Yoshikawa T; Kinoshita T; Ito S; Yokoyama H; Mochizuki Y; Ito H; Tsuburaya A; Sakamoto J; Nakao A;
    Gastric Cancer; 2010 Aug; 13(3):197-203. PubMed ID: 20820990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer.
    Takahari D; Shimada Y; Takeshita S; Nishitani H; Takashima A; Okita N; Hirashima Y; Kato K; Hamaguchi T; Yamada Y; Shirao K
    Gastric Cancer; 2010 Aug; 13(3):186-90. PubMed ID: 20820988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy.
    Shitara K; Chin K; Yoshikawa T; Katai H; Terashima M; Ito S; Hirao M; Yoshida K; Oki E; Sasako M; Emi Y; Tsujinaka T
    Gastric Cancer; 2017 Jan; 20(1):175-181. PubMed ID: 26626800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined S-1 and cisplatin preoperative chemotherapy for patients with advanced gastric cancer: report of five cases.
    Nakane Y; Inoue K; Michiura T; Nakai K; Sato M; Baden T; Okumura S; Yamamichi K
    Hepatogastroenterology; 2004; 51(55):289-93. PubMed ID: 15011888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer: a randomized controlled trial.
    Tatebe S; Tsujitani S; Nakamura S; Shimizu T; Yamane N; Nishidoi H; Kurisu Y; Kanayama H; Ogawa H; Ikeguchi M
    Gastric Cancer; 2014; 17(3):508-13. PubMed ID: 23948997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer.
    Shinchi H; Maemura K; Mataki Y; Kurahara H; Sakoda M; Ueno S; Hiraki Y; Nakajo M; Natsugoe S; Takao S
    J Hepatobiliary Pancreat Sci; 2012 Mar; 19(2):152-8. PubMed ID: 21647560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.